Daniel Patrick O'Day - 10 Mar 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chairman & CEO, Director
Signature
/s/ Amy Kim by Power of Attorney for Daniel O'Day
Issuer symbol
GILD
Transactions as of
10 Mar 2022
Net transactions value
-$640,132
Form type
4
Filing time
14 Mar 2022, 21:52:09 UTC
Previous filing
03 Mar 2022
Next filing
13 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise $0 +10,800 +4.6% $0.000000 247,193 10 Mar 2022 Direct F1
transaction GILD Common Stock Options Exercise $0 +13,203 +5.3% $0.000000 260,396 10 Mar 2022 Direct F1
transaction GILD Common Stock Tax liability $640,132 -11,052 -4.2% $57.92 249,344 10 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -10,800 -11% 85,772 10 Mar 2022 Common Stock 10,800 Direct F1, F2
transaction GILD Restricted Stock Unit Options Exercise -13,203 -15% 72,569 10 Mar 2022 Common Stock 13,203 Direct F1, F3
transaction GILD Non-qualified Stock Option (Right to Buy) Award $0 +399,235 $0.000000 399,235 10 Mar 2022 Common Stock 399,235 $57.92 Direct F4
transaction GILD Restricted Stock Unit Award +64,745 +89% 137,314 10 Mar 2022 Common Stock 64,745 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.
F3 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F4 The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.